Corporate Membership
Thanks to ANCO’s Corporate Members
The goal of ANCO’s Corporate Membership Program is to develop a comprehensive partnership between ANCO and all other organizations serving the cancer care community. ANCO thanks its current Corporate Members for their support. Learn more about our Corporate Member patient and reimbursement assistance programs.
Corporate Memberships in ANCO are available at five levels, with increasing rights and benefits at each level. Please complete the corporate membership form to become a Corporate Member. You may also download the letter of request here. Please contact Brian Hale, Member Relations Specialist, at brian@anco.org with any questions.
$40,000*
$25,000*
$15,000
$10,000
$5,000
High level recognition, a standard exhibit table**, and 1 non-sales industry registration at 2 meetings: Clinical Cancer Update, Multidisciplinary Management of Cancers, or Hematologic Malignancies Update. (Benefit not guaranteed if application is received after October 18, 2024)
Priority meeting space
Two e-blasts to ANCO members per year at no additional fee
Join 1 ANCO Committee Meeting of your choice annually
Annual Legislative Briefing (held virtually)
2 meeting registrations and a standard exhibit table** at 3 meetings: Best of SABCS, ANCO’s ASCO Highlights, Health Equity Research Summit (odd numbered years only), or Precision Oncology Symposium (even numbered years only). (Benefit not guaranteed if application is received after October 18, 2024)
Meet one-on-one with the ANCO Board of Directors annually
One social media post per quarter with your content (4 total)
Opportunity to contribute information to The ANCO Report, i.e. new product announcements, new indications, meeting announcements
Annual Meet and Greet with the Board of Directors
Discounted display opportunities at ANCO’s Highlights meetings
Active links on www.anco.org
Receive a post-event list of attendees upon request
20% discounted rate off non-member rates for exhibit fee and industry meeting registrations
At multi-day ANCO meetings, the opportunity to split badges included with exhibit space may be available at a discounted member rate of $500 per split
Recognition on www.anco.org and in the Corporate Member Directory
Receipt of The ANCO Report via e-mail
Distribute Corporate Member meeting information to ANCO membership
Invitations to ANCO clinical and professional education meetings
Display opportunities at ANCO meetings for an additional display fee
Opportunity to send e-blasts to ANCO Members at a rate of $1,500 per blast
Access to ANCO’s website for selected number of corporate members
Opportunity to contribute to Oncology News and Updates on ANCO.org
*The number of Sustaining Plus and Sustaining Corporate Members will be limited and subject to approval by the board.
**Exhibit Space includes 2 exhibitor badges.
ANCO encourages organizations with an interest in hematology/oncology to become Corporate Members of ANCO at the highest possible level. With your support, a stronger Association of Northern California Oncologists will provide its physician members, their practice contacts, and their patients with substantial benefits emanating from advocacy, education, practice guidance, and timely information. Contact the ANCO Executive Director to become a Corporate Member.
Please Note: All ANCO memberships run on the fiscal year of January 1st – December 31st. All membership fees are subject to change and due when the application is submitted, and non-refundable, if application is approved. Individual memberships are non-transferable.
ANCO acknowledges these Corporate Members whose dues have contributed to the advancement of the Association.
We also acknowledge the support of our Silver Level Corporate Members:
Adaptive Biotechnologies • ADC Therapeutics • Alexion Pharmaceuticals • Boehringer-Ingelheim • Caris Life Sciences • Coherus • Deciphera • EMD Serono • Genentech Inc, a Member of the Roche Group • Guardant Health • Natera • NeoGenomics • Sobi, Inc • SecuraBio • Servier Pharmaceuticals • Sumitomo Pharma America, Inc. • TerSera Therapeutics
“My ANCO membership and board involvement have been invaluable in enabling me to connect with colleagues beyond my sphere at Stanford. I have had the opportunity to interact with physicians at UCSF, UC Davis, the Permanente Medical Group and with numerous private practices. My participation in the enlightening Multidisciplinary Management of Cancers Meeting has enriched my career and connections with oncologists in Northern California.”
A. Dimitrios Colevas, M.D.
Professor of Medicine, Stanford University